Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "Volska 2013 Abstract MiP2013"

From Bioblast
Line 17: Line 17:
|organism=Rat
|organism=Rat
|tissues=Nervous system
|tissues=Nervous system
|preparations=Isolated Mitochondria
|preparations=Isolated mitochondria
|injuries=Ischemia-Reperfusion; Preservation
|injuries=Ischemia-reperfusion;preservation
|topics=Coupling efficiency;uncoupling
|topics=Coupling efficiency;uncoupling
|couplingstates=LEAK, OXPHOS
|couplingstates=LEAK, OXPHOS

Revision as of 13:26, 13 February 2015

Volska K, Makrecka M, Svalbe B, Dambrova M (2013) The inhibitor of L-carnitine biosynthesis protects brain mitochondria against anoxia-reoxygenation injury. Mitochondr Physiol Network 18.08.

Link:

Kristina Volska

MiP2013, Book of Abstracts Open Access

Volska K, Makrecka M, Svalbe B, Dambrova M (2013)

Event: MiP2013 Programme

L-carnitine takes part in the regulation of cellular energy metabolism. Recently it has been shown that mildronate, an inhibitor of L-carnitine biosynthesis, improves the neurological outcome after ischemic damage of brain tissue [1]. The aim of the present study was to investigate the effects of mildronate treatment on brain mitochondrial function using an in vitro model of anoxia-reoxygenation.

Wistar rats were treated daily with mildronate (per os; 100 mg/kg) for 14 days. Control animals received water. The mitochondrial respiration measurements were performed in isolated brain mitochondria with a Clark-type oxygen sensor. OXPHOS capacity was measured using ADP and various substrates to evaluate respiration of all respiratory complexes. In order to investigate anoxia-reoxygenation damage, brain mitochondria were subjected to 5 min anoxia, followed by 5 min reoxygenation. In parallel, isolated mitochondria were treated under the same conditions but without 5 min anoxia to obtain control (normoxic) measurements. Respiratory parameters were determined: LEAK respiration in the absence of ADP (LN); OXPHOS capacity (P); LEAK respiration after phosphorylation of ADP to ATP (LT); respiratory control ratio (P/LT, RCR).

Under normoxic conditions, mildronate treatment did not affect LN and P. However, LT was increased by 30%, resulting in a 28% decreased RCR. Anoxia-reoxygenation induced a significant 2.8-fold decrease in P and a 1.6-fold increase LT. These effects of anoxia-reoxygenation resulted in 4-fold reduction of the RCR. The mildronate treatment significantly diminished the anoxia-reoxygenation-induced decrease in P and increase in LT by 20% and 36%, respectively. After anoxia-reoxygenation the RCR was almost 2 times higher in the mildronate treated group compared to controls.

These results demonstrate that mildronate treatment induces uncoupling preconditioning-like effect and improves tolerance against anoxia-reoxygenation.


Labels: MiParea: Respiration, Pharmacology;toxicology 

Stress:Ischemia-reperfusion;preservation"Ischemia-reperfusion;preservation" is not in the list (Cell death, Cryopreservation, Ischemia-reperfusion, Permeability transition, Oxidative stress;RONS, Temperature, Hypoxia, Mitochondrial disease) of allowed values for the "Stress" property.  Organism: Rat  Tissue;cell: Nervous system  Preparation: Isolated mitochondria 

Regulation: Coupling efficiency;uncoupling  Coupling state: LEAK, OXPHOS 


MiP2013 

Affiliations and author contributions

1 - Riga Stradins University, Latvia; 2 - Latvian Institute of Organic Synthesis, Riga, Latvia; 3 - University of Latvia, Riga, Latvia. - Email: k.volska@inbox.lv


References

  1. Svalbe B, Zvejniece L, Vavers E, Pugovics O, Muceniece R, Liepinsh E, Dambrova M (2011) Mildronate treatment improves functional recovery following middle cerebral artery occlusion in rats. Behav Brain Res 222: 26-32.